While the injectable form is often associated with slightly faster initial weight loss due to how the body absorbs the higher doses, the oral version yields comparable long-term outcomes for many patients
Discussion In multi-omics studies, analyzing individual samples enables exploration of individual-level variability and supports robust statistical inference [24]
The 2023 international evidence-based PCOS guideline positions lifestyle modification as foundational for all women, recommends metformin for metabolic features (especially at higher BMI), notes limited benefit for inositol, and importantly recognizes that anti-obesity medications, including GLP-1-based agents, can be considered for weight management in PCOS while emphasizing that evidence in this population remains limited and largely off-label
This is particularly relevant for patients who have not achieved adequate lipid control with statins alone
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease